Clinical Trials Directory

Trials / Unknown

UnknownNCT04820608

Transepithelial Customized Cross-linking

Epithelium-on Customized Cross-linking for Keratoconus

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Ophthalmica Eye Institute · Academic / Other
Sex
All
Age
12 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Customized remodeled vision (CuRV) is a new corneal cross-linking protocol for keratoconus, combining a transepithelial approach with customized energy application. Our aim is to follow-up our patients and establish the short-and long-term results of CuRV.

Detailed description

Customized remodeled vision is a protocol for oxygen-boosted, tranespithelial cross-linking, customized to apply higher energy at the apex of the cone, relatively lower to the cone area and none to healthy cornea. Thus CuRV promises to halt keratoconus progression, simultaneously offering potential for relatively good visual rehabilitation.Our primary outcomes involve spectacle-corrected distance visual acuity and changes in corneal topography/tomography and OCT parameters. These parameters include Kmax, thinnest corneal pachymetry, maximal anterior and posterior elevation, the Fourier analysis-derived irregularity index, and demarcation line depth.

Conditions

Interventions

TypeNameDescription
DEVICECross-linkingOxygen-boosted, epithelium-on, customized cross-linking. Highest UV-A application is focused on the apex of the cone. The cone area receives a moderate amount of UV-A, while healthy cornea is spared.

Timeline

Start date
2018-02-01
Primary completion
2022-01-01
Completion
2022-01-01
First posted
2021-03-29
Last updated
2021-03-29

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04820608. Inclusion in this directory is not an endorsement.